Literature DB >> 28900043

A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia.

Thomas Suply1, Sébastien Hannedouche2, Nathalie Carte1, Jianping Li1, Bianka Grosshans1, Michael Schaefer1, Layla Raad1, Valérie Beck1, Solange Vidal1, Agnès Hiou-Feige1, Noémie Beluch1, Samuel Barbieri1, Johann Wirsching1, Nadine Lageyre1, Frank Hillger1, Corinne Debon1, Janet Dawson1, Philip Smith1, Vincent Lannoy2, Michel Detheux2, Francis Bitsch1, Rocco Falchetto1, Tewis Bouwmeester1, Jeffrey Porter3, Birgit Baumgarten1, Keith Mansfield3, José M Carballido1, Klaus Seuwen4, Frédéric Bassilana4.   

Abstract

GPR15 is an orphan G protein-coupled receptor (GPCR) that is found in lymphocytes. It functions as a co-receptor of simian immunodeficiency virus and HIV-2 and plays a role in the trafficking of T cells to the lamina propria in the colon and to the skin. We describe the purification from porcine colonic tissue extracts of an agonistic ligand for GPR15 and its functional characterization. In humans, this ligand, which we named GPR15L, is encoded by the gene C10ORF99 and has some features similar to the CC family of chemokines. GPR15L was found in some human and mouse epithelia exposed to the environment, such as the colon and skin. In humans, GPR15L was also abundant in the cervix. In skin, GPR15L was readily detected after immunologic challenge and in human disease, for example, in psoriatic lesions. Allotransplantation of skin from Gpr15l-deficient mice onto wild-type mice resulted in substantial graft protection, suggesting nonredundant roles for GPR15 and GPR15L in the generation of effector T cell responses. Together, these data identify a receptor-ligand pair that is required for immune homeostasis at epithelia and whose modulation may represent an alternative approach to treating conditions affecting the skin such as psoriasis.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28900043     DOI: 10.1126/scisignal.aal0180

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  23 in total

Review 1.  Location is important: differentiation between ileal and colonic Crohn's disease.

Authors:  Raja Atreya; Britta Siegmund
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-12       Impact factor: 46.802

2.  Endogenous Peptide Inhibitors of HIV Entry.

Authors:  Mirja Harms; Manuel Hayn; Fabian Zech; Frank Kirchhoff; Jan Münch
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Aberrant hepatic trafficking of gut-derived T cells is not specific to primary sclerosing cholangitis.

Authors:  Jonathon J Graham; Sujit Mukherjee; Muhammad Yuksel; Rebeca Sanabria Mateos; Tengfei Si; Zhenlin Huang; Xiahong Huang; Hadil Abu Arqoub; Vishal Patel; Mark McPhail; Yoh Zen; Nigel Heaton; Maria Serena Longhi; Michael A Heneghan; Rodrigo Liberal; Diego Vergani; Giorgina Mieli-Vergani; Yun Ma; Bu'Hussain Hayee
Journal:  Hepatology       Date:  2021-12-07       Impact factor: 17.425

Review 4.  Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation.

Authors:  Sebastian Zundler; Claudia Günther; Andreas E Kremer; Mario M Zaiss; Veit Rothhammer; Markus F Neurath
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-08-09       Impact factor: 73.082

5.  MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET.

Authors:  Ankit Srivastava; Cristina Tommasi; Dane Sessions; Angela Mah; Tomas Bencomo; Jasmine M Garcia; Tiffany Jiang; Michael Lee; Joseph Y Shen; Lek Wei Seow; Audrey Nguyen; Kimal Rajapakshe; Cristian Coarfa; Kenneth Y Tsai; Vanessa Lopez-Pajares; Carolyn S Lee
Journal:  Cancer Res       Date:  2022-09-02       Impact factor: 13.312

6.  Ahr-Foxp3-RORγt axis controls gut homing of CD4+ T cells by regulating GPR15.

Authors:  Lifeng Xiong; Joseph W Dean; Zheng Fu; Kristen N Oliff; John W Bostick; Jian Ye; Zongming E Chen; Marcus Mühlbauer; Liang Zhou
Journal:  Sci Immunol       Date:  2020-06-12

7.  Clonally expanded, GPR15-expressing pathogenic effector TH2 cells are associated with eosinophilic esophagitis.

Authors:  Duncan M Morgan; Bert Ruiter; Neal P Smith; Ang A Tu; Brinda Monian; Brandon E Stone; Navneet Virk-Hundal; Qian Yuan; Wayne G Shreffler; J Christopher Love
Journal:  Sci Immunol       Date:  2021-08-13

8.  Tyrosine sulfation and O-glycosylation of chemoattractant receptor GPR15 differentially regulate interaction with GPR15L.

Authors:  Yukari Okamoto; Sojin Shikano
Journal:  J Cell Sci       Date:  2021-04-22       Impact factor: 5.285

9.  Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab.

Authors:  Monali Manohar; Diane Dunham; Sheena Gupta; Zheng Yan; Wenming Zhang; Samantha Minnicozzi; Matthew Kirkey; Bryan Bunning; Roshni Roy Chowdhury; Stephen J Galli; Scott D Boyd; Laurie Elizabeth Kost; R Sharon Chinthrajah; Manisha Desai; Hans C Oettgen; Holden T Maecker; Wong Yu; Rosemarie H DeKruyff; Sandra Andorf; Kari C Nadeau
Journal:  Allergy       Date:  2021-05-29       Impact factor: 14.710

10.  Inflammatory biomarker relationships with helper T cell GPR15 expression and cannabis and tobacco smoking.

Authors:  Allan M Andersen; Man-Kit Lei; Steven R H Beach; Robert A Philibert
Journal:  J Psychosom Res       Date:  2020-12-06       Impact factor: 4.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.